Expiration Date: November 30, 2017
Media: Internet - based
This edition of Medical Crossfire® provides community oncologists with evidence-based perspectives on the rationale for current standards of care in soft tissue sarcoma (STS), clinical questions and challenges, and how to integrate optimal approaches into clinical practice. It is designed to update practitioners on advances in the field and focuses on the appropriate diagnosis of STS, multi-disciplinary management, use of new agents, and the value of appropriate referral to a sarcoma specialist under a collaborative-care model. Our program chair, George Demetri, MD, leads the program faculty, Mark Agulnik, MD, Shreyaskumar R. Patel, MD, and Richard F. Riedel in extensive panel discussions on 3 key topics. Throughout the activity, interactive online questions are posted to participants to assess their knowledge and facilitate self-assessment.
CME/CE Activity Table of Contents
George D. Demetri, MD
Module I: Tackling Clinical Challenges
Module II: Current Strategies Employed in the Management of Unresectable STS in Multiple Lines of Therapy
Module III: Emerging Strategies
Requirements for Successful Completion
Participants may immediately download a CME certificate upon completion of these steps.
This educational program is directed toward medical oncologists, surgical oncologists, and radiation oncologists in the treatment of soft tissue sarcoma. Nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with sarcoma will be invited to participate.
- Explain disease heterogeneity in advanced soft tissue sarcomas (STS) and its impact on treatment strategies and methods to overcome challenges to optimized diagnoses in the field
- Discuss novel mechanistic approaches for the care of patients with metastatic or unresectable STS
- Integrate a multimodal approach that engages community-based oncologists to communicate with sarcoma specialists to manage multimodality sequencing in multiple lines of care for patients with STS
Faculty, Staff, and Planners' Disclosures
George D. Demetri, MD
Professor of Medicine, Harvard Medical School
Director, Ludwig Center at Harvard
Director, Center for Sarcoma and Bone Oncology
Dana-Farber Cancer Institute
Disclosure: Grant/Research Support: Bayer, Novartis, Pfizer, Janssen Oncology; Consultant: Novartis, Pfizer, EMD Serono, Sanofi Oncology, Janssen Oncology, PharmaMar, Daiichi-Sankyo, Adaptimmune, Eisai, Blueprint Medicines, Kolltan Pharmaceuticals, Caris Life Sciences.
FacultyMark Agulnik, MD
Associate Professor, Medicine, Hematology Oncology Division
Feinberg School of Medicine
Northwestern Memorial Hospital
Disclosure: Speaker’s Bureau: Novartis, Janssen, Eisai.
Robert R. Herring Distinguished Professor of Medicine
Center Medical Director, Sarcoma Center
Deputy Chairman, Dept. of Sarcoma Medical Oncology
The University of Texas M.D. Anderson Cancer Center
Disclosure: Grant/Research Support: Janssen, Eisai, Morphotek; Consultant: Novartis, Janssen, Eisai, EMD- Serono, CytRx, Bayer, Lilly.
Richard F. Riedel, MD
Associate Professor, Division of Medical Oncology
Associate Director, Clinical Research, Duke Sarcoma Program
Associate Program Director, Heme-Onc Fellowship Program
Medical Director, Solid Tumor Inpatient Service
Duke University Health System
Disclosure: Grant/Research Support: Immune Design, Novartis, Lilly, Aadi Shakti, Karyopharm, Plexxikon, Merck, Tracon Threshold, Tokalas; Consultant: Lilly, EMD-Serono.
Off-Label Disclosure and Disclaimer
This CME activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.
The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians’ Education Resource®, LLC, or any of the companies that provided commercial support for this activity.
CME Provider Contact Information
666 Plainsboro Road, Suite 356
Plainsboro, NJ 08536
Toll Free: 888-949-0045
Hardware And Software RequirementsSupported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)
Minimum System Requirements (Windows)
- A Pentium-based PC or compatible computer
- At least 64MB of RAM
- Windows 95/98/NT/ME/2000/XP/Vista system software
- Screen resolution of 1024 x 786 or larger recommended
- PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise